• Science & Technology
• Health & Medicine

News digest – targeted radiation beam, precision medicine and our early detection roadmap

A new technique has been developed to help reduce a common side effect of radiotherapy for people with throat cancer. A new technique has been developed to help reduce a common side effect of radiotherapy for people with throat cancer.

17 October 2020

• Health & Medicine

Creating a shared vision to detect cancer earlier

We're bringing researchers, policy-makers, pharmaceutical companies and the public together to find a way to make early diagnosis better. We're bringing researchers, policy-makers, pharmaceutical companies and the public together to find a way to make early diagnosis better.

15 October 2020

• Health & Medicine
• Science & Technology

Scientists develop new precision medicine approach for pancreatic cancer

Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer.  Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer. 

12 October 2020

• Health & Medicine
• Science & Technology

Vital rethinking in cancer early detection needed to save lives

The Cancer Research UK Roadmap sets out a plan to overcome the challenges hampering early detection of cancer. The Cancer Research UK Roadmap sets out a plan to overcome the challenges hampering early detection of cancer.

6 October 2020

• Health & Medicine

New drug targeting high-risk children’s cancer is ready for trials

A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma. A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma.

5 October 2020

• Health & Medicine

News digest – HPV vaccine, 1 million breast screenings missed and prostate cancer treatment

Results from a new drug trial have found “one of the most promising breakthroughs for patients with this type of breast cancer in the last 20 years." Results from a new drug trial have found “one of the most promising breakthroughs for patients with this type of breast cancer in the last 20 years."

3 October 2020

• Health & Medicine

HPV vaccine reduces cervical cancer risk

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.   Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

1 October 2020

• Health & Medicine

UK health inequalities: 20,000 more cancer cases a year in the most deprived areas

New figures released today reveal that there are around 20,000 extra cancer cases each year in more deprived areas of the UK. New figures released today reveal that there are around 20,000 extra cancer cases each year in more deprived areas of the UK.

30 September 2020

• Health & Medicine

News digest – calorie guidelines, reduced lung cancer referrals and COVID-19’s impact on cancer services

Six months after the UK entered lockdown, we now have a clearer picture of how COVID-19 has affected cancer services. Six months after the UK entered lockdown, we now have a clearer picture of how COVID-19 has affected cancer services.

19 September 2020

• Health & Medicine

Lung cancer risks becoming ‘forgotten disease’ of the coronavirus pandemic  

At least 14,000 fewer people have been urgently referred for lung cancer tests since March.  At least 14,000 fewer people have been urgently referred for lung cancer tests since March. 

17 September 2020

• Health & Medicine

What’s happened to cancer services during the COVID-19 pandemic?

Six months since lockdown, we’ve got a much clearer picture how cancer services were affected, and how well they’re recovering. Six months since lockdown, we’ve got a much clearer picture how cancer services were affected, and how well they’re recovering.

11 September 2020

• Health & Medicine

Targeted drug for lung cancer approved for NHS use in England

The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer. The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer.

11 September 2020